ADVZ
"ADVZ" is a word mark owned by Mercury Pharma Group Limited, filed at the USPTO on April 1, 2022. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since September 5, 2023
- Filed
- April 1, 2022
- Registered
- September 5, 2023
- Priority date
- March 16, 2022
- Claimed from United Kingdom
- Application no.
- 97342609
- Registration no.
- 7154065
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns ADVZ
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Mercury Pharma Group Limited
London, United Kingdom
Representative
Meghna Prasad
Baker Botts L.L.P.
What the mark covers
The products and services ADVZ is filed for, grouped by Nice class.
A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations and excluding over the counter analgesic products or pain relief products
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Law office publication review completed
- Approved for pub - principal register
- Examiner's amendment entered
- Notification of examiners amendment e-mailed
- Examiners amendment e-mailed
10 earlier steps on the official record.
About ADVZ
Who owns the trademark "ADVZ"?
The USPTO trademark "ADVZ" (application 97342609) is owned by Mercury Pharma Group Limited.
What is the status of "ADVZ"?
Its status at the USPTO is: registered.
When was "ADVZ" registered?
It was registered on September 5, 2023.
Get this data via the API
Everything on this page comes from the Signa API. Pull ADVZ and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a62-65f8-75e3-a8d6-54e3d542262d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a62-65f8-75e3-a8d6-54e3d542262d",
"object": "trademark",
"mark_text": "ADVZ",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97342609",
"filing_date": "2022-04-01",
"nice_classes": [
5
],
"owners": [
{
"name": "Mercury Pharma Group Limited",
"entity_id": "ent_019ebc1c-43cc-7756-a067-ba4f307e3583"
}
]
}